To synthesize neuroanatomical and molecular evidence linking major depressive disorder (MDD) with impaired neuroplasticity and to evaluate how pharmacologic and non-pharmacologic treatments restore plasticity via neurotrophic mechanisms.
Balakrishnan et al. (Tue,) studied this question.